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Abstract
The aimof this studywas to describe current practice for insertion and care of central venous catheters (CVCs) in intensive care units (ICUs)
in Australia and to compare current practice with international guidelines. A prospective telephone survey was conducted to gather data
that describe existing practices. Amultivariate analysis of the data was conducted using clustering techniques. In the context of this study,
cluster analysis was used to find groups with similar approaches to CVC practices. Forty Australian hospitals with level 2 or 3 ICUs as
defined by ANZICS were randomly selected and four ICU nurses from each were randomly selected for interview. A total of 34 ICUs and
133 ICU nurses agreed to participate. All states and territories were represented. Themajority of CVCmanagement practices in Australian
ICUs are consistent with the latest Centers for Disease Control and Prevention (CDC) guidelines. However, practices that did not comply
with the recommendations includedmaximal sterile barrier precautions such as use of cap andmask, choice of dressing, catheter insertion
site, cleansing ofCVCport beforeCVCaccess, replacement of administration sets andCVCs, removal of CVCs and the choice of liquid soap
over antiseptic containing soap. Theheterogeneity of practice observed and thedivergence from theCDCguidelines suggests that practices
for insertion and care of CVCs in ICUs in Australia can be improved. Improved practice may result in lower rates of catheter-related
bloodstream infection, save costs and improve health outcomes.
Introduction
Hospital-acquired catheter-related bloodstream infections
(CRBSI) occur among intensive care patients at a rate of 23 per
1000 catheters in Australian hospitals.1 CRBSI are associated with
patient morbidity, mortality and economic costs.2–6 Research
conducted in Australia suggests an 11% attributable mortality
rate,7 which would result in 392 unnecessary deaths per year.
Recent preliminary estimates put the annual cost in Australia at
between $AU25.7 million and $AU95.3 million.8
Awide range of effective practices are available for the prevention
of CRBSI, including, among others, surveillance and feedback of
infection rates, preferential use of the subclavian site for insertion,
use of 2% chlorhexidine gluconate for asepsis and catheter site
care, policies regarding the timely removal of catheters, and
aseptic technique in managing the catheter.9,10 Recent evidence
has also shown the use of technological interventions such as
antimicrobial coated catheters11,12 and use of multiple concurrent
interventions in ‘bundles’13–15 to be highly effective ways of
reducing the risk of CRBSI.
Existing guidelines based on this evidence, such as CDC
guidelines for the prevention of intravascular catheter-related
infections10 orWHO guidelines on hand hygiene,16 are amodel of
best practice and can beused to judgewhether observedpractice is
optimal or not. Published studies report variation and
heterogeneity in insertion and management practices related to
CVCs, such as the exchange of catheters over a guide wire that
increase the risk of CRBSI.15,17,18 An earlier Australian study was
quite small (n= 14 ICUs) and the authors suggest it was not
representative of all ICU practice.18 Also, the pattern of practices
among ICUs was not described.
The objectives for this paper are to describe current practices for
CVC insertion and ongoing care among a representative sample of
Australian ICUs, and, to describe variation in practices among
ICUs and compare current practice to international guidelines.
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Methods
Setting and participants
Forty Australian hospitals were selected at random from 129
hospitals with level 2 or 3 ICUs as defined by the Australian and
New Zealand Intensive Care Society (ANZICS).19 Four registered
nurses who provide patient care were selected at random from
each ICU. Further detail of themethodused to choose the sample is
givenbelow.Thequestionnairewasdevelopedbyateamincluding
an infection control professional, an intensive care nurse and an
epidemiologist. Questions were included which related to each
practice mentioned in the CDC guidelines for the insertion and
management of CVCs.10 The questionnaire was piloted in five
intensive carenurses froman ICUnot included in theactual survey
sample. No questions were added or dropped but some
modifications to wording were made to increase the clarity of
questions. Telephone interviews were carried out between May
andJune2005byregisterednurseswithexperience inintensivecare
nursing and infection control. Theywere providedwith training to
conduct telephonesurveys.Thedatawererecordeddirectly intoan
electronic version of the questionnaire on a Microsoft Access
database. Participation in the surveywas voluntary.Anonymity of
participants and participating institutions was maintained.
Sampling method
We used a 2-stage cluster sampling strategy to sample ICUs and
then nurses within ICUs, with random sampling without
replacementused at each stage. To calculate sample size,weused a
formula that allowed for the two-stage cluster sampling strategy
used.20 Most previously reported estimates of catheter care
behaviour lay within the range P= 0.2–0.8,21–23 therefore sample
size calculations were designed to estimate a proportion of 50%
(where variance is maximised)24 with a precision of 11.5%. We
inflated the sample size to allow for a 15% non-response rate, and
assumed an intracluster correlation coefficient of 0.3 based on an
earlier study conducted in a hospital care setting.25 The optimal
balanceofclusters (ICUs)andindividuals (nurses) requiresa trade-
off between expense and precision,24 so we made the further
assumption that the expense of recruiting another ICU would be
greater than that of recruiting another nurse within an ICU. This
indicated that the optimal sample size was 160, comprised of 40
ICUs with four nurses in each ICU. ICUs were randomly selected
usingcomputer-generatedrandomnumbersequencesfromalistof
all level2and3ICUsacrossAustraliaasprovidedbyANZICS.Alist
of identified nursing staff was requested from each participating
ICU.This listwasreorderedtoensure that itdidnotrepresentastaff
hierarchy and nursing staff were randomly selected without
replacement via computer-generated random number sequences.
Of the 160 nurses selected 133 (83%) were willing to participate.
Interviews were arranged with the selected nurses via the head
nurse so individualparticipatingnurseswere atnopoint identified
to the person administering the questionnaire.
Survey design
Aquestionnairewas designed for the ICUnurses. Therewere nine
sections with 49 questions about CVC care. The sections were:
(i) the clinical context; (ii) staff education and training; (iii) catheter
insertion procedures; (iv) skin antisepsis before insertion and
handling of catheters; (v) dressings used to cover the insertion site;
(vi) techniques used for accessing CVC and insertion site;
(vii) techniques used for replacement of CVC or administration
set; (viii) removal and replacement of catheters; and (ix) types of
catheters used. For most questions, a 5-point Likert scale with
response options from ‘always’ to ‘never’ was applied with
further options of ‘do not know’ or ‘other’ where appropriate. In
the latter case, nurses were asked to specify the intervention in a
follow-up question.
Data analysis
The data were cleaned, checked for missing values and outliers,
and re-coded to enable a descriptive analysis of the results. A
multivariate analysis of the ICU nurse survey was conducted
using clustering techniques. Each of the questionnaire sections
was treated as a separate analysis. Cluster analysis is used in the
social sciences to characterise clusters of similar behaviours or
characteristics within samples. In the context of this study, cluster
analysis was used to find groups with similar approaches to CVC
practices. An agglomerative hierarchical case cluster analysis
method was used and variables standardised using a Z score to
allow for cross comparisons among the variables. The nine survey
sections were analysed with different combinations of distance
measures (i.e. Euclidean and city-block distance) and linkage rules
(i.e. unweighed pair-group average and single linkage). Ward’s
method was used to assess the variance between respondents and
develop meaningful clusters. The cluster solutions were
formulated topresent the distinctions betweengroups as clearly as
possible. SPSS version 14.0 software was used for all analyses
(SPSS, Chicago, IL, USA). A detailed description of the data
analysis is given below.
A descriptive analysis of each survey provided a framework of
CVC management and care. A multivariate analysis of the ICU
nurse survey using cluster analysis was conducted to determine
the existence of meaningful groups with similar approaches in
catheter management. Cluster analysis is an explanatory
technique used for generating a hypothesis that can subsequently
be formally tested in inferential methods such as MANOVA or
discriminant analysis. Preliminary steps of the cluster analysis
included checking data for missing values and outliers. Amissing
value analysis justified data imputation using the mean answer
value, as the relevant valueswere not ‘missing at random’ (P 2-tail
 0.05).26 Variables with more than 15 missing values and
variables without any variance were excluded from the analysis.
Outliers did not appear to be relevant, as confirmed by an outlier
detection using Cook’s distance. There are two reasons for this.
49
Management of central venous catheters Healthcare Infection
The data were categorical, which constrains the existence of
outliers, and the data recording was a very thorough process,
accomplished by trained professionals without time pressure. The
original 168 variables were reduced to 158 during the preliminary
analysis. An agglomerative hierarchical case cluster analysis
method was used and variables standardised using a Z score to
allow for cross comparisons among the variables. The nine survey
sectionswere analysedutilisingdifferent combinations of distance
measures (Euclidean and city-block distance) and linkage rules
(unweighed pair-group average and single linkage). As those
linkage methods form clusters based on the middling distance
between all pairs of answers given or on the distance of the two
closest response values, the clusters computed were highly
uneven across all sections.27 The concluding analysis withWard’s
method to assess the variance between respondents produced
more meaningful clusters and provided clearer dendograms.
Depending on the section, Ward’s method was combined with
Euclidean or squared Euclidean distance subject to the merit of
interpretation. Each of the relevant sections was treated as a
separate analysis and the clusters derived accordingly relate to this
particular section only. The first indicator for a suitable cluster
solution was the dendogram illustrating cluster combinations of
cases, that is respondents. A range of 2- to 5-cluster solutions was
compared, with a focus on significant dissimilarities between the
groups. As the within-group consistency is rarely 100%, the
predominant answer associatedwith a certain clusterwas decided
on to represent that cluster. Itwas a priority to include themajority
of variables, but some had to be excluded as they had not shown
any variation between the clusters or were merely trivial for
interpretation purposes. A section describing staff education and
training was omitted as the answer was ‘not applicable’ for the
majority of respondents.
Results
Variables withmore than 15missing values and variables without
any variance were excluded from the clustering procedures. The
original 168 variableswere reduced to 158.Outliers did not appear
to be relevant and this was confirmed using Cook’s distance
method. The results of the clustering procedures only are
presented in Tables 1–3. These data are augmented with results
from descriptive analyses.
Most of the 133 selected registered nurses were experienced, with
82.7% having at least 6 years clinical experience and 90.9% having
acquired formal educational qualification in critical care nursing.
Almost all had managed a CVC at least once a week (94%) within
the past 6 months. A majority of the respondents (77.4%) had
received training based on observing experienced colleagues
before undertaking supervised bedside care of CVCs themselves
and 78.6% of them believed that the training met their learning
needs very well. In total, 25.6% received a theory-only based
training and 39.8% received a combination of both theoretical and
practical components.Nearly all (97%)were aware ofwrittenCVC
management guidelines. Within the ICUs, information on CRBSI
rates was provided to ICU nursing staff: ‘always or most of the
time’ (54.9%); ‘sometimes’ (21.8%); ‘rarely or never’ (13.6%). The
majority agreed that information on the CRBSI rates would assist
in improving the quality of patient care (85%) and would assist in
reducing infection rates (82.7%). Only a small percentage of nurses
believed that information would not be useful in improving the
quality of patient care (1.5%) or would not reduce CRBSI (2.3%).
Table 1 shows a 3-cluster solution for skin antisepsis practice and
also a 4-cluster solution for CVC insertion and access practice. The
differences between clusters are highlighted in bold. Across the
surveyed ICUs, practices were similar for skin antisepsis, with
Cluster 1 representing the majority of practice patterns. Cluster 2
used ‘70% ethanol/povidone iodine 10%’ or ‘chlorhexidine
(0.5%)/ethanol (70%)’, and cluster 3 was characterised by the
longest time between application of skin antiseptic and insertion.
For all respondents (i.e. no clustering was found), the person
insertingaCVCworea capmost of the time (32.3%), amaskmost of
the time (60.2%) and always wore a sterile gown (97%) and sterile
gloves (100%). A large sterile drape was used in most insertions
(92.5%)and the catheterswereplaced in the ICU(91%)oroperating
room (26.3%). Multiple lumen catheters were the most commonly
used (93.2%), although less than half the respondents knew what
types of catheters were used most of the time. Of the respondents
who knew about catheter type, catheters without antimicrobial
coatings were used most often (38.4%). When antimicrobial
catheterswereused,themainreasonwasconsultantpreferenceand
the purpose was recognised to be to reduce the risk of CRBSI.
All clusters used chlorhexidine gluconate as a hand wash before
insertion, with Cluster 1 adopting 2% rather than 4%. The
differences in practice between clusters were due mainly to the
staff who inserted the line and the site used. Clusters 1 and 2 had
most lines inserted by registrars, with Cluster 1 preferring the
subclavian vein insertion site and Cluster 2 favouring the jugular
vein insertion site. Cluster 3 utilised registrars and residents and
had a greater propensity for the femoral site. In Cluster 4,
consultants always inserted lines and did not show a preference
between the subclavian and jugular.
Cluster 1 represents the majority strategy. These units used
needle-free access systems, swabbed with alcohol, and performed
a 30–60-s hand wash with chlorhexidine before accessing the line.
Cluster 4 was the second most popular and used a different CVC
system (injectable bung system) and a longer duration of hand
washing. Clusters 2 and 3 represent theminority practices and use
a 3-way tap system.
Table 2 shows a 3-cluster solution for CVC dressing practice.
Themajority (95.5%) of practices lie in Clusters 1 and 2, which only
50
Healthcare Infection K. Bolz et al.
differed by the concentration of the chlorhexidine gluconate hand
washsolutionused.Thealternative typeofdressingusedbyCluster
3wasPrimapore, anadhesive,non-wovendressing. Forall clusters,
the duration of hand washing before dressing the CVC was either
1–2min (63.2%) or 2–3min (25.6%). Nearly all respondents
indicated that antisepticor antibiotic ointmentwasneverapplied to
the site (95.5% and 98.5%, respectively). Routine dressing changes
were performedweekly (42.1%),whereas themajority of units only
changed dresses when clinically indicated (54.1%).
Table 3 shows a4-cluster solution for thepractice of administration
set replacement and CVC replacement. Units varied by strategies
for administration set replacement, solutions used for and
duration of hand washing, and the frequency with which they
replaced propofol products. For all respondents (i.e. no clustering
was found), administration sets were replaced at 24 h or less for
blood products following the commencement of a transfusion
(97.7%), albumin products (85.7%), total parental nutrition (TPN)
(82%) and lipid products (79.7%). There was no majority practice,
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Table 1. Results of cluster analysis illustrating differences in central venous catheter (CVC) management practice regarding
skin antisepsis, CVC insertion and CVC access in Australian intensive care units.
NA, not applicable. Differences between clusters are given in bold
Cluster 1 Cluster 2 Cluster 3 Cluster 4
a. Skin asepsis n=72 (54.1%) n= 44 (33.1%) n=17 (12.8%) NA
Skin asepsis before
CVC insertion
Chlorhexidine
(0.5%)/ethanol
(70%)
Sometimes 70%
ethanol/
povidone
iodine 10%,
sometimes
chlorhexidine
(0.5%)/ethanol
(70%)
Chlorhexidine (0.5%)
/ethanol (70%)
Time between
application of skin
asepsis and CVC
insertion
1–2 min 1–2 min 4–5 min NA
b. CVC insertion
practice
n=27 (20.3%) n= 48 (36.1%) n=45 (33.8%) n= 13 (9.8%)
Person inserting CVC Registrar mostly,
consultant
sometimes
Registrar mostly,
consultant
sometimes
Registrar mostly,
resident
sometimes
Consultant always
CVC insertion site Subclavian
mostly, jugular
sometimes
Jugular mostly,
subclavian
sometimes
Subclavian/jugular
mostly, femoral
sometimes
Subclavian/jugular
mostly
Hand wash used
before CVC
insertion
Chlorhexidine
gluconate 2%
Chlorhexidine
gluconate 4%
Chlorhexidine
gluconate 4%
Chlorhexidine
gluconate 4%
c. CVC access
practice
n=90 (67.6%) n= 8 (6.0%) n=5 (3.8%) n= 30 (22.6%)
System used for CVC
access
Needle-free 3-Way tap 3-Way tap Injectable bung
Preparation of CVC
before CVC access
Wiped with
alcohol
Wiped with
chlorhexidine
Sometimes wiped
with alcohol,
sometimes
no preparation
Wiped with
alcohol
Hand wash used
before CVC access
Chlorhexidine
gluconate 2%
Chlorhexidine
gluconate 2%
Chlorhexidine
gluconate 4%,
plain liquid soap,
sometimes
alcohol rub
Chlorhexidine
gluconate 4%
Duration of hand
washing before
CVC access
31–60 s 31 s–2 min 16–60 s 31 s–2 min
Management of central venous catheters Healthcare Infection
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Table 2. Central venous catheter (CVC) dressing clusters: results of cluster analysis illustrating differences in CVC practice regarding
CVC dressing in Australian intensive care units.
Cluster 1 Cluster 2 Cluster 3
n= 81 (60.9%) n= 46 (34.6%) n= 6 (4.5%)
Dressing used immediately after
CVC insertion
Transparent polyurethane Transparent polyurethane Other type of dressing
Dressing used during ongoing
CVC care
Transparent polyurethane Transparent polyurethane Other type of dressing
Hand wash used before
CVC dressing
Chlorhexidine gluconate 2% Chlorhexidine gluconate 4% Chlorhexidine gluconate 2%
Table 3. Results of cluster analysis illustrating differences in CVC practice regarding the replacement of administration sets and CVC
replacement in Australian intensive care units.
Differences between clusters are given in bold
Cluster 1 Cluster 2 Cluster 3 Cluster 4
a. Replacement of
administration sets
n= 54 (40.6%) n= 37 (27.8%) n= 31 (23.3%) n= 11 (8.3%)
Hand wash used
before replacement
of administration sets
Chlorhexidine
gluconate 2%
Chlorhexidine
gluconate 4%
Plain liquid
soap
Chlorhexidine
gluconate 2%,
sometimes
alcohol rub
Duration of hand
washing before
replacement of
administration sets
31–60 s 1–2 min 16–30 s 16 s–2min
Frequency of
replacement
for total parental
nutrition
24 h or less 24 h or less 24 h or less 49–72 h
Frequency of
replacement for
propofol products
7–12 h 13–24 h 7–48h 13–24h
b. CVC
replacement
n= 38 (28.6%) n= 42 (31.6%) n= 46 (34.6%) n= 7 (5.2%)
How often is CVC
removed?
If CVC in place, not
used and peripheral
line suffices for
intravenous
administration
Most of the time Always Always/most
of the time
Never
CVC routine
replacement
Only when
clinically
indicated
Only when
clinically
indicated
Every 7 days Only when clinically
indicated/every
7 days
CVC replacement
over a guidewire
Sometimes Rarely Rarely Never
How often is the new
catheter inserted
at a new site at the
patient?
Most of the time Always Always Always
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with catheter replacement over a guidewire unpopular and use of
anew insertion site favoured. For all respondents (i.e. no clustering
was found), most participants (66.9%) monitored the line site for
signs of infection or other complications once per shift and
recorded doing so. About 30% of respondents (i.e. no clustering
was found) reported examining the site every 2 to 3h.According to
the respondents, CVCs would always be removed if signs of local
(85%) or CRBSI (72.2%) were present.
Discussion
This survey provides a snapshot of current practices associated
with the management of CVCs in Australian ICUs. Variation
between interventions used for the insertion and ongoing care of
CVCs is highlighted. Different antiseptic solutions were used for
hand washing, insertion sites varied, and there were different
regimes for changing dressings or replacing administration sets
andCVCs.Theuseof cluster analysis togroup the responses shows
patternsandnatural associationswith thedataandsodescribes the
range of clinical practices for CVC care in Australian ICUs.
The CDC10 develops evidence-based guidelines for the
management of intravascular catheters, including insertion and
ongoing care of CVCs. The guidelines are updated frequently, the
most recent update being in 2002. The recommendations are not
specific to ICUpatients, althoughanyparticular applications to the
ICU environment are highlighted. We found that most practices
reported in the Australian setting concur with those
recommended by CDC.
For skin antisepsis, the CDC guidelines10 suggest: ‘Disinfect clean
skin with an appropriate antiseptic before catheter insertion and
during dressing changes. Although a 2% chlorhexidine-based
preparation is preferred, tincture of iodine, and iodophor, or 70%
alcohol can be used (Category IA).’ They also suggest: ‘Allow the
antiseptictoremainontheinsertionsiteandtoairdrybeforecatheter
insertion. Allow povidone iodine to remain on the skin for at least
2min or longer if it is not yet dry before insertion (Category IB).’
Even though none of the clusters in Table 1a used the preferred 2%
chlorhexidine-based solution for skin antisepsis before CVC
insertion, all of them used alternatives containing a 70% alcohol.
The majority of respondents were in Clusters 1 and 3 (66.9%) and
applied a skin antisepsis that was reasonable but not best practice.
For CVC insertion, the CDC recommendation is that: ‘The
comprehensive strategy should include [. . .] educating persons
who insert andmaintain catheters. Designate personnel who have
been trained andexhibit competency in the insertionof catheters to
supervise trainees who perform catheter insertion (Category IA).’
‘Use a subclavian site (rather than a jugular or a femoral site) in
adult patients to minimise infection risk for nontunneled CVC
placement (Category IA).’ ‘Observe proper hand-hygiene
procedures either bywashing handswith conventional antiseptic-
containing soap andwater or with waterless alcohol-based gels or
foams [. . .] before and after inserting [. . .] an intravascular catheter
(Category IA).’
In Table 1b, Cluster 1 (20.3%) meets the suggested guidelines for
CVC insertion. The insertion site is mostly the subclavian and the
hand wash used prior is chlorhexidine gluconate 2%. CVC
insertion practice requires improved adherence to guidelines by
the majority.
For CVC access, the authors of the CDC guidelines suggest:
‘Attempts to reduce the incidence of sharp injuries and the
resultant risk for transmission of blood borne infections to health-
careworkers have led to the design and introduction of needle-less
infusion systems. When the devices are used according to
manufacturers’ recommendations, they do not substantially affect
the incidence of CRBSI.’ ‘Clean injection ports with 70% alcohol or
an iodophor before accessing the system (Category IA).’ ‘Observe
proper hand-hygiene procedures either by washing hands with
conventional antiseptic-containing soap and water or with
waterless alcohol-based gels or foams [. . .] before and after
accessing [. . .] an intravascular catheter (Category IA).’
Cluster 1 (67.6%) is closest to theCDCguideline (see Table 1c). The
preferred chlorhexidine gluconate 2% is used for hand washing
before accessing the CVC, the CVC port is wipedwith alcohol and
a needle-free CVC system is used. The recommended duration of
hand washing with soap and water is 40–60 s.16 The members of
the remaining clusters adhere to only parts of the guideline.
For CVC dressing, the recommendation is: ‘Use either sterile
gauze or sterile, transparent, semi-permeable dressing to cover the
catheter site (Category IA).’ ‘Observe proper hand-hygiene
procedures either bywashing handswith conventional antiseptic-
containing soap andwater or with waterless alcohol-based gels or
foams [. . .] before and after dressing [. . .] an intravascular catheter
(Category IA).’
Most participating ICU nurses (60.9%) follow best practice,
as illustrated by Cluster 1 in Table 2. The other clusters either did
not use the recommended dressing or washed their hands
with chlorhexidine gluconate 4% instead of chlorhexidine
gluconate 2%.
For the replacement of administration sets, the guidance is to:
‘Observe proper hand-hygiene procedures either by washing
hands with conventional antiseptic-containing soap and water or
with waterless alcohol-based gels or foams [. . .] before and after
replacing [. . .] an intravascular catheter (Category IA).’ ‘Replace
tubing used to administer blood, blood products, or lipid
emulsions (those combinedwith amino acids andglucose in a 3-in-
1 admixture or infused separately)within 24 hours of initiating the
infusion (Category IB).’ ‘If the solution contains only dextrose and
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amino acids, the administration set does not need to be replaced
more frequently than every 72 hours (Category II).’ ‘Replace
tubing used to administer Propofol infusions every 6 or 12 hours,
depending on its use, per the manufacturer’s recommendation
(Category IA).’
Clusters 1 and 4 in Table 3a adhere to hand wash
recommendations. As we did not specify TPN products in the
survey we cannot state a preferred frequency of replacement.
Cluster 1 (40.6%) replaces propofol products every 7–12h and
overall applies best practice.
ForCVCreplacement, theadvice is: ‘Donot routinelyreplaceCVCs
[. . .] (Category IB).’ ‘Do not use guidewire exchanges routinely for
nontunneled catheters to prevent infection (Category IB).’
In Table 3b, no clustermeets the recommendation. Clusters 3 and 4
deviate from good practice by routinely replacing CVC every
7 days. This would probably not increase infection risk, but may
potentially expose patients to additional risks of insertion such as
pneumothorax and bleeding. Only Cluster 4 avoids guidewire
exchanges completely.
The cluster analysis interpretations of CVC care revealed
strengths and flaws of current practice in Australian ICUs.
For CVC access and dressing, more than two-thirds were
adherent to best practice according to CDC guidelines; in all
other sections, only the minority were following the
recommendation.
Strengths of this survey are the inclusion of a representative
sample of randomly selected ICUs and a high response rate. All
respondents were bedside nurses providing care for patients with
CVCs, with a majority experienced in caring for a CVC and
trained in the management of catheters and used guidelines in
management of catheters. However, the fact that the survey was
conducted as an interview could have distorted the answers due
to social desirability. To minimise this over-reporting of ‘best’
practices, anonymity of respondents was maintained by
conducting the interviews by telephone. Since no observation of
actual practices was undertaken it is not possible to judge how
closely the survey results reflect actual practice. Warren et al15
note that self reports of infection control practices can be
inaccurate. On that account, research including direct
observational studies could be a way to elucidate current practice
further. This survey focussed on the perception of nurses as they
are responsible for most of the care and management of CVC,
even though the interviewed nurses were not the person actually
inserting the CVCs.
Improved practice could not only lead to decreased infection rates
and better health outcomes but also reduce costs. Decisions about
how risks should be managed require data that describe the
economic costs and health benefits of all competing infection
control programmes28,29 to be organised in an economic
evaluation. This information is largely missing from the
literature.30Aprerequisite for goodquality economic evaluation is
an understanding of existing practices used for the insertion and
ongoing care of CVCs. Changes to costs and health benefits of
additional infection-control programmes can be estimated with
modelling studies.30
Conclusion
There was evidence that practice among health care professionals
working in Australian ICUs was adequate but not entirely
compliant with CDC guidelines. There is room for improvement
with: consistent use of maximal sterile barrier precautions; choice
of transparent or gauze dressing always over Primapore;
preferential use of subclavian insertion site for nontunneled CVC
placement; cleaning the injection site with 70% alcohol or an
iodophor prior to CVC access; change of administration sets for
(i) Propofol, 12 hours (ii) Lipid products and lipid containing
TPN, 24 hours (iii) Non-lipid TPN, >72 hours; use of an
antiseptic-containing soap before applying a dressing, accessing a
CVC or replacing an administration set; no routine replacement of
CVCs in absence of any signs of infection; and, prompt removal of
any catheters that are not in use.
A recent initiative of the Centre of Healthcare Related Infection
Surveillance and Practice (CHRISP), Queensland Health, is to
provide evidence-based support to healthcare professionals
related to the insertion and management of six intravascular
devices. The I-Care eToolkit was developed by critically
appraising the literature including existing guidelines, which
addressed the scope of the project.31 The practices identified in the
guidelines outline a baseline of optimal practice which units
should follow. Once this is achieved this baseline can also be used
to compare the introduction of additional novel infection control
interventions, for example the use of antimicrobial catheters or the
adoption of a ‘bundled’ strategy.13 It is not clear which is the best
method to enhance compliance with existing evidence based
guidelines. There is increasing experience that the checklist
approach as advocated by the influential work of Berenholtz
and collegues13 may provide a cost-effective method to reduce
CRBSI by improving practices but further research on this is
required.
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